ArticleOncotarget2018

Recombinant methioninase combined with doxorubicin (DOX) regresses a DOX-resistant synovial sarcoma in a patient-derived orthotopic xenograft (PDOX) mouse model.

Kentaro Igarashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.